Publication | Closed Access

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

VaccinationCervical Cancer ScreeningHpv-16/18 As04-adjuvanted VaccineCervical CancerCervical HealthHuman Papillomavirus VaccinesVaccine ResearchVaccine TrialGynecologyPathologyGrade 3Vaccine EfficacyPublic HealthImmunotherapyMedicineDouble-blind Patricia TrialPrecancerous Lesions